The European Union's pharmaceutical sector is in a constant state of evolution. With exacting regulations, increasing patient needs, and the rapid pace of research, navigating this complex landscape requires a prudent approach. Pharmaceutical companies must adjust to these challenges by integrating advanced technologies, working with key stakeholde